Jasper Therapeutics Shares Decline Following Announcement of 1-for-30 Reverse Stock Split
Jasper Therapeutics (JSPR) shares experienced a significant decline of over 14% on Wednesday following the company's announcement of a 1-for-30 reverse stock split. The corporate action is scheduled to take effect on November 6, 2026. Post-split, the company expects to have approximately 1.11 million shares of common stock issued and outstanding, a substantial reduction from the current level of nearly 33.3 million shares. Such moves are often viewed by markets as attempts to increase share price or meet exchange listing requirements.
Coverage
- Marketing Worldwide Executes 1-for-350 Reverse Stock Split
- Jasper Therapeutics to execute 1-for-30 reverse stock split
- Jasper Therapeutics Shares Decline Following Announcement of 1-for-30 Reverse Stock Split
- FutureCorp Space Acquisition 1 - 10-Q Filing
- Robo.ai Inc. Reaffirms 1-for-25 Reverse Stock Split to Meet Nasdaq Listing Requirements